Northern Trust’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-54,472
| Closed | -$74K | – | 4873 |
|
2021
Q4 | $74K | Buy |
54,472
+8,128
| +18% | +$11K | ﹤0.01% | 4509 |
|
2021
Q3 | $135K | Buy |
46,344
+116
| +0.3% | +$338 | ﹤0.01% | 4322 |
|
2021
Q2 | $161K | Sell |
46,228
-141,648
| -75% | -$493K | ﹤0.01% | 4228 |
|
2021
Q1 | $643K | Sell |
187,876
-5,786
| -3% | -$19.8K | ﹤0.01% | 3741 |
|
2020
Q4 | $3.72M | Buy |
193,662
+29,585
| +18% | +$568K | ﹤0.01% | 2847 |
|
2020
Q3 | $2.2M | Sell |
164,077
-2,567
| -2% | -$34.5K | ﹤0.01% | 3019 |
|
2020
Q2 | $7.06M | Buy |
166,644
+31,771
| +24% | +$1.35M | ﹤0.01% | 2311 |
|
2020
Q1 | $3.72M | Sell |
134,873
-20,278
| -13% | -$560K | ﹤0.01% | 2475 |
|
2019
Q4 | $5.04M | Sell |
155,151
-4,548
| -3% | -$148K | ﹤0.01% | 2579 |
|
2019
Q3 | $4.16M | Buy |
159,699
+52,410
| +49% | +$1.36M | ﹤0.01% | 2657 |
|
2019
Q2 | $3.94M | Buy |
107,289
+3,305
| +3% | +$121K | ﹤0.01% | 2680 |
|
2019
Q1 | $2.3M | Buy |
103,984
+12,434
| +14% | +$275K | ﹤0.01% | 2988 |
|
2018
Q4 | $1.29M | Buy |
91,550
+9,125
| +11% | +$128K | ﹤0.01% | 3269 |
|
2018
Q3 | $1.6M | Buy |
82,425
+7,915
| +11% | +$154K | ﹤0.01% | 3318 |
|
2018
Q2 | $1.65M | Buy |
74,510
+4,204
| +6% | +$92.8K | ﹤0.01% | 3297 |
|
2018
Q1 | $1.49M | Buy |
+70,306
| New | +$1.49M | ﹤0.01% | 3249 |
|